医中誌リンクサービス


文献リスト

1)国立がん研究センターがん対策情報センター.全国がん罹患モニタリング集計 2003-2005年生存率報告.2013.国立がん研究センターがん研究開発費「地域がん登録精度向上と活用に関する研究」平成22年度報告書
医中誌リンクサービス
2)Özdemir BC, Pentcheva-Hoang T, Carstens JL, et al. Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival. Cancer Cell. 2014; 25: 719-34
PubMed CrossRef
医中誌リンクサービス
3)Rhim AD, Oberstein PE, Thomas DH, et al. Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma. Cancer Cell. 2014; 25: 735-47
PubMed CrossRef
医中誌リンクサービス
4)Sherman MH, Yu RT, Engle DD, et al. Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy. Cell. 2014; 159: 80-93
PubMed CrossRef
医中誌リンクサービス
5)Sinn M, Denkert C, Striefler JK, et al. α-Smooth muscle actin expression and desmoplastic stromal reaction in pancreatic cancer: results from the CONKO-001 study. Br J Cancer. 2014; 111: 1917-23
PubMed CrossRef
医中誌リンクサービス
6)Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol. 2009; 9: 162-74
PubMed
医中誌リンクサービス
7)Clark CE, Hingorani SR, Mick R, et al. Dynamics of the immune reaction to pancreatic cancer from inception to invasion. Cancer Res. 2007; 67: 9518-27
PubMed CrossRef
医中誌リンクサービス
8)Bayne LJ, Beatty GL, Jhala N, et al. Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer. Cancer Cell. 2012; 21: 822-35
PubMed CrossRef
医中誌リンクサービス
9)Stromnes I, Brockenbrough JS, Izeradjene K, et al. Targeted depletion of MDSC subset unmasks pancreatic ductal adenocarcinoma to adaptive immunity. Gut. 2014; 63: 1769-81
PubMed CrossRef
医中誌リンクサービス
10)Satoh K, Hamada S, Shimosegawa T. Involvement of epithelial to mesenchymal transition in the development of pancreatic ductal adenocarcinoma. J Gastroenterol. 2015; 50: 140-6
PubMed CrossRef
医中誌リンクサービス
11)Wang L, Yang H, Abel EV, et al. ATDC induces an invasive switch in KRAS-induced pancreatic tumorigenesis. Genes Dev. 2015; 29: 171-83
PubMed CrossRef
医中誌リンクサービス
12)Li Y, VandenBoom TG 2nd, Kong D, et al. Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells. Cancer Res. 2009; 69: 6704-12
PubMed CrossRef
医中誌リンクサービス
13)Hamada S, Satoh K, Fujibuchi W, et al. MiR-126 acts as a tumor suppressor in pancreatic cancer cells via the regulation of ADM9. Mol Cancer Res. 2012; 10: 3-10
PubMed CrossRef
医中誌リンクサービス
14)Nakata K, Ohuchida K, Mizumoto K, et al. Micro RNA-373 is down-regulated in pancreatic cancer and inhibits cancer cell invasion. Ann Sug Oncol. 2014; 21: S564-74
医中誌リンクサービス
15)Hamada S, Satoh K, Miura S, et al. MiR-197 induces epithelial-mesenchymal transition in pancreatic cancer cells by targeting p120 catenin. J Cell Physiol. 2013; 228: 1255-63
PubMed CrossRef
医中誌リンクサービス
16)Harazono Y, Muramatsu T, Endo H, et al. miR-655 is an EMT-suppressive microRNA targeting ZEB1 and TGFBR2. PLoS One. 2013; 8: e62757
CrossRef
医中誌リンクサービス
17)Ouyang H, Gore J, Deitz S, et al. microRNA-10b enhances pancreatic cancer cell invasion by suppressing TIP30 expression and promoting EGF and TGF-β actions. Oncogene. 2014; 33: 4664-74
PubMed CrossRef
医中誌リンクサービス
18)Costa-Silva B, Aiello NM, Ocean AJ, et al. Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Nat Cell Biol. 2015 May 18. doi: 10.1038/ncb3169. [Epub ahead of print]
医中誌リンクサービス
19)von Karstedt S, Conti A, Nobis M, et al. Cancer Cell-Autonomous TRAIL-R Signaling Promotes KRAS-Driven Cancer Progression, Invasion, and Metastasis. Cancer Cell. 2015; 27: 561-73
PubMed CrossRef
医中誌リンクサービス
20)Lemke J, Noack A, Adam D, et al. TRAIL signaling is mediated by DDR4 in pancreatic tumor cells despite the expression of functional DR5. J Mol Med. 2010; 88: 729-40
医中誌リンクサービス
21)Yang S, Wang X, Contino G, et al. Pancreatic cancers require autophagy for tumor growth. Genes Dev. 2011; 25: 717-29
PubMed CrossRef
医中誌リンクサービス
22)Rosenfeldt MT, O’Prey J, Morton JP, et al. p53 status determines the role of autophagy in pancreatic tumor development. Nature. 2013; 504: 296-300
PubMed CrossRef
医中誌リンクサービス
23)Yang A, Rajeshkumar NV, Wang X, et al. Autophagy is critical for pancreatic tumor growth and progression in tumors with p53 alterations. Cancer Discov. 2014; 4: 905-13
PubMed CrossRef
医中誌リンクサービス


NPO医学中央雑誌刊行会
https://www.jamas.or.jp/
info@jamas.or.jp